Motor prediction errors—mismatches between intended and actual motor outcomes—are increasingly recognized as critical contributors to functional disability across a spectrum of neurological and psychiatric conditions. These errors disrupt the brain’s capacity to anticipate, plan, and execute movements, leading to impaired functional performance and often exacerbating disability. This review synthesizes current scientific understanding of motor prediction errors, integrating recent evidence from functional neuroimaging, computational neuroscience, and clinical research to elucidate their epidemiology, pathophysiological mechanisms, risk factors, clinical presentation, diagnosis, and management. Emphasis is placed on the clinical relevance of motor prediction errors in disorders such as stroke, Parkinson’s disease, functional neurological disorder (FND), and chronic pain syndromes. We also discuss therapeutic approaches—including rehabilitation, neuromodulation, and cognitive interventions—aimed at mitigating prediction error burden, as well as recent advances in guideline-based management strategies.
The ability to predict the sensory consequences of one’s own movements is fundamental to motor control and daily function. Motor prediction errors occur when there is a discrepancy between expected and actual sensory feedback during movement execution. This phenomenon is not only crucial for motor learning but also central to the pathogenesis and persistence of functional disability in a diverse array of clinical populations. Mounting evidence suggests that maladaptive prediction error signals can perpetuate abnormal movement patterns, contribute to fatigue, and hinder recovery. Understanding the neurobiological substrates and clinical ramifications of motor prediction errors is essential for developing targeted interventions that restore functional capacity and quality of life.
Motor prediction errors contribute significantly to the burden of functional disability worldwide. In stroke survivors, approximately 30-60% experience persistent motor deficits linked to aberrant prediction signaling. In Parkinson’s disease, impaired motor prediction is implicated in bradykinesia, freezing, and dyskinesias, affecting millions globally. Functional neurological disorder (FND), characterized by abnormal motor symptoms without structural pathology, has a prevalence of up to 50 per 100,000 and is strongly associated with prediction error mechanisms. Chronic pain syndromes, such as complex regional pain syndrome (CRPS), also involve dysfunctional sensory-motor prediction and are major sources of disability. The societal impact is profound, encompassing reduced independence, increased healthcare utilization, and diminished quality of life.
Motor prediction errors arise from disrupted integration between central motor planning and peripheral sensory feedback. The brain generates an internal model that predicts the outcome of voluntary actions; when actual feedback deviates from this prediction, an error signal is generated. Key neural substrates include the cerebellum, sensorimotor cortex, basal ganglia, and parietal cortex. In stroke, lesions disrupt corticospinal connectivity and error correction loops. In Parkinson’s disease, dopaminergic deficits impair basal ganglia-mediated error processing. In FND, aberrant attention to bodily sensations and altered sense of agency amplify prediction errors, perpetuating functional symptoms. Chronic pain patients often display maladaptive plasticity in sensory-motor circuits, leading to persistent error signals and impaired motor adaptation.
Numerous factors predispose individuals to maladaptive motor prediction errors. Neurological injury (e.g., stroke, traumatic brain injury), neurodegenerative diseases (e.g., Parkinson’s, Huntington’s), psychiatric comorbidities (e.g., anxiety, depression), and chronic pain conditions increase vulnerability. Genetic predisposition, age-related neuroplasticity decline, and environmental factors such as inactivity or poor rehabilitation engagement also modulate risk. Psychological factors—such as heightened somatic focus, dysfunctional beliefs about movement, and catastrophizing—can exacerbate the impact of prediction errors, particularly in functional disorders.
Patients with prominent motor prediction errors often present with motor clumsiness, incoordination, abnormal postures, tremor, freezing, or gait disturbances that are disproportionate to structural findings. Fatigue, sense of effort, and subjective disability are common. In FND, symptoms may fluctuate and be influenced by attention, stress, or suggestion. In Parkinson’s disease, prediction errors contribute to both hypokinetic and hyperkinetic phenomena. Chronic pain syndromes may manifest with avoidance, protective posturing, or paradoxical movement responses, reflecting persistent prediction errors. Careful clinical assessment is necessary to distinguish these features from other neurological or musculoskeletal causes.
Diagnosis of motor prediction error-related disability relies on comprehensive clinical evaluation supported by functional neuroimaging, kinematic analysis, and neurophysiological testing. Functional MRI and positron emission tomography can reveal aberrant activation in prediction error networks. Electromyography and motion capture systems quantify deviations between intended and performed movements. In FND, positive signs such as inconsistency or incongruity of symptoms are diagnostic. A multidisciplinary approach incorporating neurology, psychiatry, rehabilitation, and neuropsychology is often required for accurate diagnosis and management planning.
Effective management of motor prediction error-related disability necessitates a multimodal strategy. Rehabilitation therapies—including task-specific training, sensorimotor retraining, and graded exposure—aim to recalibrate prediction models through repetitive practice and feedback. Cognitive behavioral therapy addresses maladaptive beliefs and attentional biases. Pharmacological interventions (e.g dopaminergic agents in Parkinson’s disease) can modulate prediction error processing. In functional disorders, psychoeducation and multidisciplinary rehabilitation are cornerstone approaches. Tailoring interventions to individual error profiles and comorbidities enhances outcomes.
Emerging therapies targeting motor prediction errors include noninvasive brain stimulation (e.g, transcranial magnetic stimulation, transcranial direct current stimulation), which can modulate cortical excitability and error correction. Virtual reality and immersive biofeedback systems provide real-time sensory feedback, facilitating error recalibration and neuroplasticity. Computational modeling is increasingly used to personalize therapy by identifying individual error signatures. Early-phase clinical trials are evaluating the efficacy of pharmacological agents targeting glutamatergic and GABAergic systems involved in prediction processing. These innovations hold promise for more precise and effective management of functional disability.
Current guidelines emphasize the importance of early identification and comprehensive management of motor prediction error-related disability. Interdisciplinary assessment is recommended, integrating neurological, psychological, and rehabilitative expertise. Evidence supports the use of individualized, task-oriented rehabilitation and cognitive interventions, particularly in FND and post-stroke populations. In Parkinson’s disease, motor and non-motor symptom management should address prediction error mechanisms. Ongoing monitoring and adjustment of therapy in response to patient progress are essential. Guidelines increasingly recognize the value of patient education and empowerment in optimizing functional outcomes.
Motor prediction errors represent a pivotal mechanism underlying functional disability in diverse clinical contexts. Advances in neurobiological understanding and therapeutic intervention are transforming the management of these complex disorders. Clinicians must maintain a high index of suspicion for prediction error-related impairment and employ guideline-based, multidisciplinary strategies to optimize recovery and functional independence. Continued research into the neural substrates and modulation of motor prediction errors will further enhance clinical practice and patient outcomes in the years ahead.
1.
A new way to measure suicide risk?
2.
3D virtual staining technology enables non-invasive observation of cancer tissue
3.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation